Viyash Scientific Limited has announced its financial results for the first quarter of FY27, ending June 30, 2026. The company reported a significant year-on-year growth, with Revenues at ₹9,464 Million, up by 19.5%. EBITDA also saw a substantial increase of 59.2% to ₹2,047 Million, while Profit After Tax (PAT) surged by 114.9% to ₹793 Million.
Viyash Scientific Reports Robust Q1 FY27 Performance
Viyash Scientific Limited, formerly known as Sequent Scientific Limited, has declared its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026 (Q1 FY27). The company demonstrated strong growth momentum, driven by its integrated platform strategy.
Key Financial Highlights for Q1 FY27:
- Revenues: ₹9,464 Million, an increase of 19.5% compared to Q1 FY26.
- EBITDA*: ₹2,047 Million, marking a growth of 59.2% over the previous year.
- PAT (Profit After Tax): ₹793 Million, a substantial rise of 114.9% year-on-year.
- Net Debt/EBITDA* ratio: stood at 0.1x.
EBITDA* is calculated excluding ESOP costs.
Consolidated Financial Performance (in millions):
| Q1FY27 | Q1FY26 | Growth % | |
|---|---|---|---|
| Revenues | 9,464 | 7,916 | 19.5% |
| EBITDA* | 2,047 | 1,286 | 59.2% |
| EBITDA* % | 21.6% | 16.2% | |
| PAT | 793 | 369 | 114.9% |
Management Commentary
Dr Hari Babu Bodepudi, Managing Director and Group CEO, commented on the company’s performance: “Our performance in Q1 FY27 reflects the continued success of our integration efforts and the strength of the combined entity. This quarter’s results are underpinned by robust execution, improving operating leverage, and a well-defined growth strategy. The acquisition of Bio For Life in Italy is a significant step in advancing our strategic focus on the companion animal segment, providing us with market access and a platform to launch our product portfolio in key European markets. As we move forward, our focus remains on disciplined execution, operational efficiency, and strategic investments in line with our long-term strategy for sustainable growth.”
Earnings Call Details
Viyash Scientific Limited will conduct an Earnings Call with investors on August 12, 2026, at 3:30 PM IST. Management will discuss the Company’s performance and answer questions from participants. The dial-in numbers for the conference call are +91 22 6280 1263 or +91 22 7115 8213.
Source: BSE
